Institute of Science Tokyo · Graduate School of Medical and Dental Sciences · 教授

Research keywordsT-cell receptor therapy・acute myeloid leukemia・prostate cancer・humanized mouse models・integrative transcriptomics・chemical screening・hematopoiesis・enhancer transcription・immuno-oncology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Nadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, Dyantha I van der Lee, Dennis F G Remst, Sophie-Anne I Smith, M Willy Honders, Renate S Hagedoorn, Arnoud H de Ru, Masashi Matsuda, Fumihiko Ishikawa, Tamar Tak, Peter J M Valk, Mirjam H M Heemskerk, Peter A van Veelen, J H Frederik Falkenburg, Marieke Griffioen. A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia. Leukemia. 2026.02; 40 (2): 265-278. ( PubMed , DOI )2026
• Marei Omori, Tomoki Yaguchi, Chisato Jimbo, Kouhei Hagino, Daisuke Harama, Daichi Suzuki, Kotaro Umezawa, Fumi Ishikawa, Seiko Hirai, Kenji Toyokuni, Tatsuki Fukuie, Yukihiro Ohya, Kiwako Yamamoto-Hanada. Integrating Behavioral Science-Based Interventions in the Treatment of Refractory Atopic Dermatitis and Associated Behavioral Problems. JMA J. 2026.01; 9 (1): 404-406. ( PubMed , DOI )2026
• Weijia Zang, Yui Koike, Koutarou Nishimura, Atsushi Tanaka, Hiromi Yamazaki, Takaya Yamasaki, Hiromi Ito, Yifan Zhang, Yumi Aoyama, Wataru Saika, Muran Xiao, Chihiro Hasegawa, Hiroyoshi Kunimoto, Hideaki Nakajima, Fumihiko Ishikawa, Akifumi Takaori-Kondo, Daichi Inoue. BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemia. Sci Rep. 2025.10; 15 (1): 37099. ( PubMed , DOI )2025
• Shigeo Toda, Naoko Inoshita, Shuichiro Matoba, Yusuke Maeda, Kosuke Hiramatsu, Yudai Fukui, Yutaka Hanaoka, Masashi Ueno, Hiroya Kuroyanagi, Fumihiko Ishikawa, Kenichi Ohashi. Lateral Pelvic Recurrence in Rectal Cancer Is Not Local Recurrence but Lymphatic Metastasis. J Anus Rectum Colon. 2025; 9 (2): 225-236. ( PubMed , DOI )2025